Literature DB >> 19651110

Noradrenergic innervation of hypophysiotropic thyrotropin-releasing hormone-synthesizing neurons in rats.

Tamás Füzesi1, Gábor Wittmann, Ronald M Lechan, Zsolt Liposits, Csaba Fekete.   

Abstract

Hypophysiotropic thyrotropin-releasing hormone (TRH)-synthesizing neurons, the central regulators of the hypothalamic-pituitary-thyroid axis, are located in the paraventricular nucleus of the hypothalamus (PVN). These neurons are well-known to be stimulated by cold exposure through activation of ascending brainstem pathways, and are heavily innervated by catecholaminergic axons that contain dopamine-beta-hydroxylase (DBH) and phenylethanolamine-N-methyltransferase (PNMT), enzymes that generate noradrenaline and adrenaline, respectively. However, whether noradrenergic cell groups that lack PNMT contribute to the innervation of TRH neurons is not known. Therefore, triple-labeling immunofluorescence was performed using antibodies against DBH, PNMT and proTRH to determine the relative involvement of adrenaline-synthesizing and noradrenergic neurons in the innervation of TRH neurons in the PVN of rats. Using confocal microscopy, the number of PNMT/DBH (adrenaline-synthesizing) and single-labeled DBH (noradrenergic) boutons juxtaposed to proTRH neurons was quantified. Both noradrenergic and PNMT-containing varicosities were observed in close apposition to virtually all proTRH neurons. An average of 11.8+/-0.6 PNMT-containing and 7.4+/-1.0 noradrenergic boutons was present on the surface of proTRH cell bodies and proximal dendrites. Of all catecholaminergic axon-varicosities juxtaposed to proTRH neurons, 63.5+/-1.2% contained PNMT while the remaining 36.5+/-1.2% were immunopositive for DBH only. We conclude that both adrenaline-synthesizing and noradrenergic axons innervate hypophysiotropic TRH neurons, although there is a predominance of adrenaline-synthesizing fibers. Since adrenaline-synthesizing and noradrenergic cell groups of the brainstem may respond differently to various physiological stimuli, we hypothesize that the two cell groups are likely to mediate the effects of distinct stimuli toward the hypophysiotropic TRH neurons.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19651110      PMCID: PMC2764741          DOI: 10.1016/j.brainres.2009.07.094

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  36 in total

1.  Central administration of neuropeptide Y reduces alpha-melanocyte-stimulating hormone-induced cyclic adenosine 5'-monophosphate response element binding protein (CREB) phosphorylation in pro-thyrotropin-releasing hormone neurons and increases CREB phosphorylation in corticotropin-releasing hormone neurons in the hypothalamic paraventricular nucleus.

Authors:  Sumit Sarkar; Ronald M Lechan
Journal:  Endocrinology       Date:  2003-01       Impact factor: 4.736

2.  Neuropeptide Y has a central inhibitory action on the hypothalamic-pituitary-thyroid axis.

Authors:  C Fekete; J Kelly; E Mihály; S Sarkar; W M Rand; G Légrádi; C H Emerson; R M Lechan
Journal:  Endocrinology       Date:  2001-06       Impact factor: 4.736

3.  Differential responses of thyrotropin-releasing hormone (TRH) neurons to cold exposure or suckling indicate functional heterogeneity of the TRH system in the paraventricular nucleus of the rat hypothalamus.

Authors:  E Sánchez; R M Uribe; G Corkidi; R T Zoeller; M Cisneros; M Zacarias; C Morales-Chapa; J L Charli; P Joseph-Bravo
Journal:  Neuroendocrinology       Date:  2001-12       Impact factor: 4.914

4.  Cocaine- and amphetamine-regulated transcript peptide-immunoreactivity in adrenergic C1 neurons projecting to the intermediolateral cell column of the rat.

Authors:  Siok L Dun; Yee Kong Ng; G Cristina Brailoiu; Eng Ang Ling; Nae J Dun
Journal:  J Chem Neuroanat       Date:  2002-02       Impact factor: 3.052

5.  Medullary adrenergic neurons contribute to the neuropeptide Y-ergic innervation of hypophysiotropic thyrotropin-releasing hormone-synthesizing neurons in the rat.

Authors:  Gábor Wittmann; Zsolt Liposits; Ronald M Lechan; Csaba Fekete
Journal:  Neurosci Lett       Date:  2002-05-10       Impact factor: 3.046

6.  alpha-Melanocyte-stimulating hormone is contained in nerve terminals innervating thyrotropin-releasing hormone-synthesizing neurons in the hypothalamic paraventricular nucleus and prevents fasting-induced suppression of prothyrotropin-releasing hormone gene expression.

Authors:  C Fekete; G Légrádi; E Mihály; Q H Huang; J B Tatro; W M Rand; C H Emerson; R M Lechan
Journal:  J Neurosci       Date:  2000-02-15       Impact factor: 6.167

7.  Association of cocaine- and amphetamine-regulated transcript-immunoreactive elements with thyrotropin-releasing hormone-synthesizing neurons in the hypothalamic paraventricular nucleus and its role in the regulation of the hypothalamic-pituitary-thyroid axis during fasting.

Authors:  C Fekete; E Mihály; L G Luo; J Kelly; J T Clausen; Q Mao; W M Rand; L G Moss; M Kuhar; C H Emerson; I M Jackson; R M Lechan
Journal:  J Neurosci       Date:  2000-12-15       Impact factor: 6.167

8.  Origin of cocaine- and amphetamine-regulated transcript (CART)-immunoreactive innervation of the hypothalamic paraventricular nucleus.

Authors:  Csaba Fekete; Gábor Wittmann; Zsolt Liposits; Ronald M Lechan
Journal:  J Comp Neurol       Date:  2004-02-09       Impact factor: 3.215

9.  Efferent projections of thyrotropin-releasing hormone-synthesizing neurons residing in the anterior parvocellular subdivision of the hypothalamic paraventricular nucleus.

Authors:  Gábor Wittmann; Tamás Füzesi; Praful S Singru; Zsolt Liposits; Ronald M Lechan; Csaba Fekete
Journal:  J Comp Neurol       Date:  2009-07-20       Impact factor: 3.215

10.  Transcriptional regulation of the thyrotropin-releasing hormone gene by leptin and melanocortin signaling.

Authors:  M Harris; C Aschkenasi; C F Elias; A Chandrankunnel; E A Nillni; C Bjøorbaek; J K Elmquist; J S Flier; A N Hollenberg
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

View more
  7 in total

Review 1.  Hindbrain noradrenergic A2 neurons: diverse roles in autonomic, endocrine, cognitive, and behavioral functions.

Authors:  Linda Rinaman
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-10-20       Impact factor: 3.619

2.  Strategies for therapeutic hypometabothermia.

Authors:  Shimin Liu; Jiang-Fan Chen
Journal:  J Exp Stroke Transl Med       Date:  2012-01-01

Review 3.  Ascending projections from the caudal visceral nucleus of the solitary tract to brain regions involved in food intake and energy expenditure.

Authors:  Linda Rinaman
Journal:  Brain Res       Date:  2010-03-27       Impact factor: 3.252

4.  Relaxin-3/RXFP3 signalling in mouse hypothalamus: no effect of RXFP3 activation on corticosterone, despite reduced presynaptic excitatory input onto paraventricular CRH neurons in vitro.

Authors:  C Zhang; D V Baimoukhametova; C M Smith; J S Bains; Andrew L Gundlach
Journal:  Psychopharmacology (Berl)       Date:  2017-03-17       Impact factor: 4.530

Review 5.  Central regulation of hypothalamic-pituitary-thyroid axis under physiological and pathophysiological conditions.

Authors:  Csaba Fekete; Ronald M Lechan
Journal:  Endocr Rev       Date:  2013-12-13       Impact factor: 19.871

6.  Family members CREB and CREM control thyrotropin-releasing hormone (TRH) expression in the hypothalamus.

Authors:  Franck Chiappini; Preeti Ramadoss; Kristen R Vella; Lucas L Cunha; Felix D Ye; Ronald C Stuart; Eduardo A Nillni; Anthony N Hollenberg
Journal:  Mol Cell Endocrinol       Date:  2012-09-20       Impact factor: 4.102

Review 7.  How to Differentiate General Toxicity-Related Endocrine Effects from Endocrine Disruption: Systematic Review of Carbon Disulfide Data.

Authors:  Nathalie Printemps; Brigitte Le Magueresse-Battistoni; Sakina Mhaouty-Kodja; Catherine Viguié; Cécile Michel
Journal:  Int J Mol Sci       Date:  2022-03-15       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.